OpenSAFELY
Reports

Vaccine Coverage

Description
Fortnightly* report on COVID-19 vaccination coverage in England, based on the population of 23.4m people registered with practices that use TPP SystmOne software. * updates may occasionally be subject to delay
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
22 Dec 2020
Last updated
18 Jan 2022
Links

OpenSAFELY COVID Vaccine coverage report

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of 17 March 2021) in our paper available here.

The full analytical methods behind the latest results in this report are available here.

Update: As of 17th January 2022, our vaccine reports will be published fortnightly. If you rely on weekly data updates for your own reporting or analysis please email [email protected] to let us know.

Report last updated 17 Jan 2022

Vaccinations included up to 12 Jan 2022 inclusive

Contents:

Overview of Vaccination Figures to date

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home. ####
first dose as at 12 Jan 2022 second dose as at 12 Jan 2022 third dose as at 12 Jan 2022
Group
Total vaccinated in TPP 16,749,999 15,910,755 12,292,497
80+ 96.9% (1,052,968 of 1,086,876) 96.0% (1,043,210 of 1,086,876) 91.7% (996,548 of 1,086,876)
70-79 96.4% (2,018,597 of 2,094,743) 95.5% (1,999,795 of 2,094,743) 91.7% (1,921,500 of 2,094,743)
care home 97.0% (106,841 of 110,145) 93.6% (103,054 of 110,145) 85.5% (94,213 of 110,145)
shielding (aged 16-69) 92.0% (758,597 of 824,838) 89.3% (736,344 of 824,838) 74.1% (611,548 of 824,838)
65-69 94.1% (1,023,904 of 1,088,668) 92.7% (1,009,687 of 1,088,668) 87.5% (952,889 of 1,088,668)
LD (aged 16-64) 88.4% (75,460 of 85,330) 84.1% (71,757 of 85,330) 65.2% (55,657 of 85,330)
60-64 92.5% (1,209,404 of 1,307,999) 90.9% (1,188,936 of 1,307,999) 83.2% (1,088,836 of 1,307,999)
55-59 90.6% (1,394,134 of 1,538,110) 88.8% (1,366,302 of 1,538,110) 78.5% (1,208,165 of 1,538,110)
50-54 88.4% (1,398,698 of 1,582,637) 86.2% (1,364,202 of 1,582,637) 73.0% (1,155,735 of 1,582,637)
40-49 81.2% (2,430,883 of 2,992,787) 78.0% (2,334,150 of 2,992,787) 58.3% (1,745,912 of 2,992,787)
30-39 72.2% (2,444,358 of 3,386,754) 66.9% (2,265,571 of 3,386,754) 40.8% (1,380,127 of 3,386,754)
18-29 70.5% (2,476,397 of 3,514,273) 62.3% (2,188,410 of 3,514,273) 30.3% (1,063,531 of 3,514,273)
16-17 67.2% (359,737 of 535,514) 44.7% (239,337 of 535,514) 3.3% (17,836 of 535,514)

NB Patient counts are rounded to nearest 7

Second doses are at least 19 days after the first; third doses at least 8 weeks after the second;

All second and third/booster doses given in these timescales are counted whether or not they were 'due' according to the relevant dosing schedule at the time.

Vaccine types

Note: numbers may not sum to 100% as it is not always possible to determine vaccine type given, and patients occasionally have more than one brand recorded on the same day.

Oxford-AZ vaccines (% of all first doses): 50.1% (8,395,233)

Pfizer vaccines (% of all first doses): 47.1% (7,884,128)

Moderna vaccines (% of all first doses): 2.8% (472,143)

Second doses and dose combinations

Note: second dose figures are raw proportions and do not take into account how many are due, which is likely to vary substantially by brand.
For more detailed analysis please refer to our second dose report

Second doses (% of all vaccinated): 95.0% (15,910,755)

Second doses (% of Ox-AZ first doses): 98.6% (8,281,882)

Second doses (% of Pfizer first doses): 92.0% (7,249,634)

Second doses (% of Moderna first doses): 80.9% (382,046)


Note: mixed doses counts patients with first and second doses at least 19 days apart, excluding patients with two different brands recorded on the same day or recorded on a date prior to when the given brand was available in the UK

Mixed doses Ox-AZ + Pfizer (% of fully vaccinated): 0.6% (88501)

Mixed doses Ox-AZ + Moderna (% of fully vaccinated): 0.1% (14441)

Mixed doses Moderna + Pfizer (% of fully vaccinated): 0.1% (19334)

Summary Charts

Note: 'Priority groups' only includes those identified as being in a priority group by our methodology. 'Others' includes everyone aged 18-49 except those who are shielding or have a learning disability.

Trends in vaccination rates of 80+ population according to demographic/clinical features, cumulatively by day.

*Latest overall cohort rate calculated as at latest date for vaccinations recorded across all TPP practices.

80+ population

COVID vaccinations among 80+ population

by Sex

COVID vaccinations among 80+ population

by Ethnicity (broad categories)

COVID vaccinations among 80+ population

by Index of Multiple Deprivation (quintiles)

COVID vaccinations among 80+ population

by BMI